ARMISTICE CAPITAL, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Aptose Biosciences Inc. Common Shares, no par value (APTO)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Aptose Biosciences Inc. Common Shares, no par value
Symbol: APTO
Shares outstanding: 20.5M shares
Disclosed Ownership: 1.03M shares
Ownership: 4.99%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 16:57:42 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	4.99%	1.03M	0	1.03M	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	4.99%	1.03M	0	1.03M	/s/ Steven Boyd	Steven Boyd